ArticleJournal of clinical orthopaedics and trauma2025
Future perspectives after the guidelines of degenerative cervical myelopathy: A narrative review.
Article in Journal of clinical orthopaedics and trauma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Degenerative cervical myelopathy (DCM) is the most common cause of spinal cord dysfunction in adults, often resulting from cervical spondylotic myelopathy (CSM) or ossification of the posterior longitudinal ligament (OPLL). As the aging population increases, the prevalence of DCM is expected to rise, making the optimization of treatment strategies crucial. While surgical decompression is widely accepted for moderate to severe cases, the management of mild DCM remains controversial. Some studies report significant neurological improvement with surgery, while others find no difference between surgical and conservative approaches. Current guidelines suggest conservative management may be considered for mild cases, with surgical intervention recommended if symptoms progress or do not respond to non-operative treatment. Non-surgical approaches such as cervical traction therapy and orthotic treatment have been explored, though their long-term effectiveness remains unclear. Pharmacological treatments, including NSAIDs, muscle relaxants, and corticosteroids, are commonly prescribed for symptomatic relief, yet their effectiveness in treating myelopathy-specific symptoms has not been established. According to current guidelines, patients with a modified Japanese Orthopaedic Association (mJOA) score of 15 or higher are considered suitable candidates for conservative management. However, surgical intervention should be considered if there is evidence of symptom progression. Surgical strategies for DCM vary based on the severity and location of spinal cord compression. The Japanese CSM and OPLL guidelines have extensively compared different surgical approaches. For CSM treatment, while anterior cervical discectomy and fusion (ACDF) and laminoplasty provide similar neurological recovery, ACDF offers better sagittal alignment but carries a higher risk of reoperation. Comparisons between ACDF and posterior decompression and fusion (PDF) indicate that both procedures yield comparable neurological outcomes, though ACDF has been associated with better patient-reported quality of life. In OPLL patients, anterior surgery may be preferable for those with severe kyphosis and extensive anterior compression, despite an increased risk of complications. Future research should focus on refining diagnostic tools, optimizing surgical decision-making, and assessing the effectiveness of conservative management strategies. Standardizing intraoperative ultrasonography criteria, evaluating the role of postoperative cervical collar immobilization, and investigating rehabilitation protocols are key areas requiring further study.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.